Torys is distinguished by its niche expertise in medical cannabis, where it advises key industry participants on regulatory, IP and commercial matters. The multidisciplinary practice is anchored by regulatory specialist Eileen McMahon, who chairs the IP, agriculture and food and drug regulatory teams. The Toronto-based group also includes Teresa Reguly, who specializes in IP and regulatory issues in the chemical, biochemical and pharmaceutical fields; counsel Yolande Dufresne, who focuses on IP and regulatory law concerning life sciences; and senior associate Melanie Sharman Rowand.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘A very knowledgeable team with high-quality attorneys.’
‘Eileen McMahon is very good with excellent client engagement. Teresa Reguly is also very engaged and provides excellent strategic advice.’
Key clients
- Canaccord Genuity Corp
- BMO Nesbitt Burns and BMO Capital Markets
Work highlights
Advised Canaccord Genuity Corp and GMP Securities on a proposed securities class action alleging primary and secondary market misrepresentations by Wayland Group Corp (formerly Maricann Group).
Advised BMO Nesbitt Burns and BMO Capital Markets, as the agents, on Canopy Growth Corporation’s $250m cross-border at-the-market offering.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Yolande Dufresne
Practice head
Eileen McMahon
Other key lawyers
Teresa Reguly; Yolande Dufresne; Melanie Sharman Rowand